Double-blind, placebo controlled study of the efficacy and safety of lisdexamfetamine dismesylate in adults with attention-deficit/hyperactivity disorder - Adler, L; Goodman, D W; Kollins, S H (J Clin Psychiatry, 2008)
et al.